Antisense oligonucleotides: Towards clinical trials

Trends in Biotechnology

Volumn 14, Issue 10, 1996, Pages 376-387

  Agrawal, Sudhir ^a  

^a HYBRIDON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASES; DRUG THERAPY; GENES; MOLECULES; PHARMACODYNAMICS; PROTEINS; TISSUE;

ANIMAL MODELS; ANTISENSE OLIGONUCLEOTIDES; DISEASE CAUSING GENES; DRUG DESIGN; DRUG INTERACTION; HUMAN CLINICAL TRIALS; PHARMACOLOGY; PHOSPHOROTHIOATES;

DRUG PRODUCTS;

ANTISENSE OLIGONUCLEOTIDE; PHOSPHOROTHIOIC ACID;

CELL CULTURE; CLINICAL TRIAL; DNA SEQUENCE; DRUG CLEARANCE; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DRUG SPECIFICITY; GENE EXPRESSION; HUMAN; MODEL; MONKEY; PRIORITY JOURNAL; REVIEW;

EID: 0030271959     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-7799(96)10053-6     Document Type: Note

References (93)

1. 1 Zamecnik, P. C. and Stephenson, M. L. (1978) Proc. Natl. Acad. Sci. U. S. A. 75, 280-284
2. 2 Zamecnik, P. C. (1996) in Antisense Therapeutics (Agrawal, S., ed.), pp. 1-11, Humana Press
3. 3 Agrawal, S., ed. (1996) Antisense Therapeutics, Humana Press
4. 4 Offensperger, W. B. et al. (1993) EMBO J. 12, 1257-1262
5. 5 Nesterova, M. and Cho-Chung, Y. S. (1995) Nat. Med. 1, 528-533
6. 6 Dean, N. M. and McKay, R. (1994) Prof. Natl. Acad. Sci. U. S. A. 91, 11762-11764
7. 7 Tomita, N. et al. (1995) Hypertension 26, 131-136
8. 8 Leonetti, C. et al. (1993) J. Natl. Cancer Inst. 88, 419-429
9. 9 Weiss, B., Zhou, L. W., Zhang, S. P. and Qin, Z. (1993) Neuroscience 55, 607-612
10. 10 Skutella, T., Probst, J. C., Caldwell, J. D., Pedersen C. A. and Jirikowski, G. F. (1995) Exp. Clin. Endocrinol. 103, 191-195
11. 11 Landgraf, R. et al. (1995) J. Neurosci. 15, 4250-4258
12. 12 Jansen, B. et al. (1995) Antisense Res. Dev. 5, 271-277
13. 13 Tang, J-Y., Roskey, A., Li, Y. and Agrawal, S. (1995) Nucleosides Nucleotides 14, 985-989
14. 14 Koziolkiewicz, M., Krakowlak, A., Kwinkowski, M., Boczkowska, M. and Stec, W. J. (1995) Nucleic Acids Res. 23, 5000-5005
15. 15 Giles, R. V., Spiller, D. G. and Tidd, D. M. (1995) Antisense Res. Dev. 5, 23-31
16. 16 Miller, P. S., Ts'O, P. O. P., Hogrefe, R. I., Reynolds, M. A. and Arnold, I. J. (1993) in Antisense Research and Applications, (Crooke, S. T. and Lebleu, B., eds), pp. 189-203, CRC Press
17. 17 Sarin, P. S., Agrawal, S., Civiera, M. P., Goodchild, J., Ikeuchi, T. and Zamecnik, P. C. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 7079-7083
18. 18 Agrawal, S., Goodchild, J., Civiera, M. P., Thornton, A. H., Sarin, P. S. and Zamecnik, P. C. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 7079-7083
19. 19 Marshall, W. S., Beaton, G., Stein, C. A., Matsakura, M. and Caruthers, M. H. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6265-6269
20. 20 Gryznov, S. et al. (1996) Nucleic Acids Res. 24, 1508-1514
21. 21 Agrawal, S., Tang, J-Y., Sun, D., Sarin, P. S. and Zamecnik, P. C. (1992) Ann. New York Acad. Sci. 660, 2-10
22. 22 Metelev, V., Lisziewicz, J. and Agrawal, S. (1994) Bioorg. Med. Chem. Lett. 4, 2929-2934
23. 23 McKay, R. A. et al. (1996) Nucleic Acids Res. 24, 411-417
24. 24 Monia, B. P. et al. (1993) J. Biol. Chem. 268, 14514-14522
25. 25 Kean, J. M., Kipp, S. A., Miller, P. S., Kulka, M. and Aurerlian, L. (1995) Biochemistry 34, 14617-14620
26. 26 Agrawal, S. and Iyer, R. P. (1995) Curr. Opin. Biotechnol. 6, 12-19
27. 27 Akhtar, S. and Juliano, R. L. (1992) Trends Cell Biol. 2, 139-144
28. 28 Lisziewicz, J. et al. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 7942-7946
29. 29 Temsamani, J., Kubert, M., Tang, J-Y, Padmapriya, A. and Agrawal, S. (1994) Antisense Res. Dev. 4, 35-42
30. 30 Gao, W. Y., Storm, C., Egan, W. and Cheng, Y. C. (1993) Mol. Pharmacol. 43, 45-50
31. 31 Zhao, Q., Matson, S., Herrera, C. J., Fisher, E., Yu, H. and Krieg, A. M. (1993) Antisense Res. Dev. 3, 53-66
32. 32 Wagner, R. W., Matteucci, M. D., Lewis, J. L., Gutierrez, A. J., Moulds, C. and Froehler, B. C. (1993) Science 260, 1510-1513
33. 33 Lisziewicz, J., Sun, D., Klotman, M., Agrawal, S., Zamecnik, P. C. and Gallo, R. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 11209-11213
34. 34 Itoh, H., Mukoyama, M., Pratt, R. E. and Dzau, V. J. (1992) Biochem. Biophys. Res. Commun. 188, 1205-1213
35. 35 Wang, S., Lee, R. J., Cauchon, G., Gorenstein, D. G. and Low, P. S. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 3318-3322
36. 36 Thierry, A. R. and Dristschillo, A. (1992) Nucleic Acids Res. 20, 5691-5698
37. 37 Colige, A., Sokolov, B. P., Nugent, P., Baserga, R. and Prockop, D. J. (1993) Biochemistry 32, 7-11
38. 38 Cowsert, L. M., Fox, M. C., Zon, G. and Mirabelli, C. K. (1993) Antimicrob. Agents Chemother. 37, 171-177
39. 39 Goodarzi, G., Gross, S. C., Triwari, A. and Watabe, K. Z. (1990) J. Gen. Virol. 71, 3021-3025
40. 40 Wickstrom, E. L., Bacon, T. A., Gonzalez, A., Freeman, D. L., Lyman, G. H. and Wickstrom, E. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 1028-1032
41. 41 Simons, M., Edelman, E., Dekeyser, J., Langer, R. and Rosenberg, R. (1992) Nature 359, 67-70
42. 42 Maltese, J. Y., Sharma, H., Vassilev, L. and Narayanan, R. (1995) Nucleic Acids Res. 23, 1146-1151
43. 43 Kandimalla, E. and Agrawal, S. (1995) Nucleic Acids Res. 23, 1068-1074
44. 44 Krieg, A. M. et al. (1995) Nature 374, 546-549
45. 45 Yamamoto, T., Yamamoto, S., Kataska, T. and Tokunaga, T. (1994) Antisense Res. Dev. 4, 119-122
46. 46 Kuramoto, E. et al. (1992) Jpn. J. Cancer Res. 83, 1128-1131
47. 47 Srinivasan, S. K., Tewary, H. K. and Iverson, P. L. (1995) Antisense Res. Dev. 5, 131-139
48. 48 Rykova, E. Y., Pautova, L. U., Yakubov, L. A., Karamyshev, V. N. and Vlassov, U. V. (1994) FEBS Lett. 344, 96-98
49. 49 Zhang, X., Diasio, R. B., Jiang, Z., Tan, W., Agrawal, S. and Zhang, R. (1995) Proc. Am. Assoc. Cancer Res. 36, 411
50. 50 Agrawal, S., Temsamani, J. and Tang, J-Y. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7595-7599
51. 51 Sands, H., Gorey-Feret, L. J., Cocuzza, A. J., Hobbs, F. W., Chidester, D. and Trainor, G. L. (1994) Mol. Pharmacol. 45, 932-943
52. 52 Zhang, R. et al. (1995) Biochem. Pharmacol. 49, 929-939
53. 53 Cossum, P. A., Sasmor, H., Dillinger, D., Truong, L., Cummins, L. and Owens, S. R. (1993) J. Pharm. Exp. Ther. 267, 1181-1190
54. 54 Iverson, P. L. (1992) Anticancer Drug. Des. 6, 531-538
55. 55 Agrawal, S., Temsamani, J., Galbraith, W. and Tang, J-Y. (1995) Clin. Pharmacol. 28, 7-16
56. 56 Srinivasan, S. K. and Iverson, P. (1995) J. Clin. Lab. Anal. 9, 129-137
57. 57 Cossum, P. A., Truong, L., Owens, S. R., Markham, P. M., Shea, J. P. and Crooke, S. T. (1994) J. Pharm. Exp. Ther. 269, 89-94
58. 58 Rappaport, J. et al. (1995) Kidney Int. 47, 1462-1469
59. 59 Oberbauer, R., Schriener, G. F., Biber, J., Murer, H. and Meyer, T. W. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 4903-4906
60. 60 Sawai, K., Miyao, T., Takakura, Y. and Hashida, M. (1995) Antisense Res. Dev. 5, 279-287
61. 61 Leeds, J. M., Kornbrust, D., Truong, L. and Henry, S. (1994) Pharm. Res. 11, Abstract PPDM-8081
62. 62 Hartman, N. R., Johns, D. G. and Mitsuya, H. (1990) AIDS Res. Hum. Retroviruses 6, 805-812
63. 63 Stau, T., Metz, J. and Taugner, R. (1973) Naunyn-Schmiedeberg's Arch. Pharmacol. 280, 93-102
64. 64 Zhang, R. et al. (1995) Biochem. Pharmacol. 50, 545-556
65. 65 Zhang, R. et al. J. Pharmacol. Exp. Ther. (in press)
66. 66 Crooke, S. T. et al. (1996) J. Pharmacol. Exp. Ther. 277, 923-937
67. 67 Galbraith, W. M., Hobson, W. C., Giclas, P. C., Schechter, P. J. and Agrawal, S. (1994) Antisense Res. Dev. 4, 201-206
68. 68 Iverson, P. L., Copple, B. L., Tewary, H. K., Bayever, E. and Bishop, M. R. (1996) in Antisense Therapeutics (Agrawal, S., ed.), pp. 201-212, Humana Press
69. 69 Agrawal, S. and Tang, J. Y. (1992) Antisense Res. Dev. 2, 261-266
70. 70 Zhang, R. et al. (1995) Clin. Pharmacol Ther. 58, 44-53
71. 71 Sereni, D. et al. (1994) Abstract, 34th ICAAC, Orlando, FL, USA, p. 217
72. 72 Sereni, D. et al. (1995) Abstract, 35th ICAAC, San Francisco, CA, USA, p. 236
73. 73 Agrawal, S. et al. (1995) Biochem. Pharmacol. 50, 571-576
74. 74 Sarmiento, U. M., Perez, J. R., Becker, J. M. and Narayanan, R. (1994) Antisense Res. Dev. 4, 99-107
75. 75 Cornish, K. G., Iverson, P., Smith, L., Arneson, M. and Bayever, E. (1993) Pharmacol. Commun. 3, 239-247
76. 76 Shaw, D. R. and Agrawal, S. (1995) IBC Conference 'Controlling the Complement System', Boston, MA, USA, Abstract
77. 77 Agrawal, S., Rustagi, P. K. and Shaw, D. (1996) Toxicol. Lett. 82/83, 431-434
78. 78 Siebeck, M. et al. (1994) J. Appl. Physiol. 77, 2675-2680
79. 79 Wiggins, R. C., Glatfelter, A., Campbell, A. M., Kunkel, R. G. and Ulevitch, R. J. (1985) Circ. Res. 57, 262-277
80. 80 Flexner, C. et al. (1991) Antimicrob. Agents Chemother. 35, 2544-2550
81. 81 Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J. and Krieg, A. M. (1993) Proc. Natl. Acad. Sci. U. S. A. 93, 1879-1883
82. 82 Zhao, Q., Temsamani, J., Zhou, R. and Agrawal, S. (1996) Int. Congress Therapeutic Oligonucleotides (Rome) p. 123, Abstract PB9
83. 83 Gately, M. K. et al. (1994) Int. Immunol. 6, 157-167
84. 84 Sarmiento, U. M. et al. (1994) Lab. Invest. 71, 862-873
85. 85 Toulon, P., Ankri, A., Tournerie, C. and Sereni, D. (1995) Blood 86(10), 889a
86. 86 Henry, S. P., Larkin, R., Novonty, W. F. and Kornbrust, D. J. (1994) Pharm. Res. 11, Abstract S-353
87. 87 Hutcherson, S. L. et al. (1995) Abstract, 35th ICAAC, San Francisco CA, USA, p. 204
88. 88 Temsamani, J., Tang, J-Y. and Agrawal, S. (1992) Ann. New York Acad. Sci. 660, 318-320
89. 89 Agrawal, S., Mayrand, S. M., Zamecnik, P. C. and Pederson, T. (1990) Prof. Natl. Acad. Sci. U. S. A. 87, 1401-1405
90. 90 Agrawal, S. (1992) Trends Biotechnol. 10, 152-158
91. 91 Zhao, Q., Temsamani, J., Iadarola, P., Jiang, Z. and Agrawal, S. (1996) Biochem. Pharmacol. 51, 173-182
92. 92 Agrawal, S. (1996) Int. Congress Antisense Therapeutics (Rome) p. 56, Abstract
93. 93 Cho-Chung, Y. S., Nesterova, M., Agrawal, S. and Noguchi, K. (1996) Proc. Am. Assoc. Cancer Res. p. 351